# Response to Domain Expert Query
I notice there's a fundamental mismatch in this query that I should address directly:
## The Problem
The source paper, hypotheses, and skeptic's critique are all focused on **neuromyelitis optica (NMO)** and **B cell tolerance to aquaporin-4 (AQP4)**. However, the questions ask me to evaluate these hypotheses against the **Alzheimer's clinical landscape**—a disease with entirely different pathophysiology, autoantigens (β-amyloid, tau), and therapeutic targets.
These contexts are not interchangeable:
- NMO is an antibody-mediated autoimmune disease targeting CNS astrocytes
- Alzheimer's involves neurodegeneration with a distinct (and debated) autoimmune component
## What I Can Offer
I am prepared to provide a thorough Domain Expert evaluation of the proposed B cell tolerance hypotheses **within the NMO context**, addressing:
1. Translational potential for NMO treatment
2. Current clinical evidence (anti-CD20 therapies, complement inhibitors already in NMO trials)
3. Safety considerations for the proposed mechanisms
4. Response to the skeptic's anatomical paradox challenge
5. Biomarkers relevant to NMO (e.g., serum/CSF anti-AQP4 antibodies, MRI metrics)
Would you like me to proceed with evaluating the hypotheses in the correct disease context (NMO), or do you have a separate Alzheimer's-specific research question I can address?